Form 4 for LFMD LifeMD, Inc.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001362118-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-05 | 2023-01-03 | LFMD | FRIEDEMAN JESSICA | CMO | A - Grant | — | +150.0K | 150.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | A | A | 150,000 | — | 150,000 | D | — | — | (F1) Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 150,000 restricted shares, with 50,000 vesting on January 3, 2024, 50,000 vesting on January 3, 2025 and 50,000 vesting on January 3, 2026. |